Position in AVTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$522,614
+$138,466 QoQ
Shares Held
28,280
+9.9% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 126 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $148,775,467 across 46 Biotechnology names. AVTX ranks #31 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
538,822 | $61,080,861 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
488,546 | $12,360,212 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
206,405 | $11,810,493 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
141,317 | $11,060,881 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,621 | $10,987,396 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,722 | $6,319,398 | |
| 7 | VCEL |
Vericel Corp
|
139,921 | $6,225,084 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
7,637 | $2,413,979 |
All Filings in AVTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $522,614 | 28,280 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $384,148 | 25,730 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $371,372 | 20,450 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||